# ScriptCo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/scriptco

- Industry: Retail
- Headquarters: Woodway, US
- Website: www.scriptco.com/
- Latest round: Seed (May 1, 2023)
- Investors on record: 1

## About

ScriptCo Inc. is a membership-based pharmacy that provides affordable access to generic prescription medications, shipped directly to members' homes.ScriptCo Inc., founded in 2019, operates as a pharmacy focused on generic medications, catering specifically to individuals without health insurance. The company is based in Woodway, US. In May 2023, ScriptCo secured Seed funding, marking its most recent financial move. The founder's details are not currently available.ScriptCo Pharmacy operates as a membership-based pharmacy specializing in the provision of generic prescription medications at actual wholesale costs. The company's primary service is to supply members with affordable access to generic drugs, which are shipped directly to their homes, eliminating the need for visits to a traditional pharmacy. ScriptCo exclusively deals with generic medications and does not dispense controlled substances or brand-name products. The company targets individuals who lack health insurance or find their current prescription costs prohibitively high, offering significant savings compared to traditional pharmacy pricing. ScriptCo's clientele includes a diverse range of end users across the United States, particularly appealing to those managing chronic conditions such as diabetes, as well as seniors enrolled in Medicare Part D programs.ScriptCo generates revenue through a membership subscription model, with options including quarterly and annual membership plans. The quarterly membership incurs a fee of USD 50, while the annual membership is priced at USD 140, offering members assurance of receiving medications at wholesale prices without the acceptance of insurance. Members benefit from free shipping on a specified number of non-refrigerated packages annually, enhancing the appeal of the service. Transactions occur directly between ScriptCo and its members, who pay for their prescriptions at the same rates ScriptCo acquires them. This structure allows for transparency in pricing, as members are informed of the costs upfront, aligning the company’s revenue model with its commitment to affordability in prescription medication access.Following the Seed funding raised in May 2023, ScriptCo Inc. is focused on expanding its operations. The company plans to introduce new generic medications aimed at chronic condition management, with launch dates expected in late 2023. Additionally, ScriptCo aims to penetrate new geographic markets, specifically targeting underserved areas in the Midwest and Southeast regions of the United States by mid-2024. The recent funding will be utilized to enhance marketing efforts and streamline the supply chain to support these initiatives.

## Funding rounds

- Seed, May 1, 2023 — Blue Collective
- Seed, Apr 22, 2022 — Blue Collective

## Investors

- Blue Collective (https://capitalatlas.ai/funds/blue-collective) — Seed